|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 25.52 USD | +0.18% |
|
+0.24% | +58.15% |
| May. 10 | Deciphera Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| May. 01 | North American Morning Briefing : Traders Wait for -2- | DJ |
Deciphera Pharmaceuticals, Inc. reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported revenue was USD 45 million compared to USD 33.45 million a year ago. Net loss was USD 45.08 million compared to USD 49.61 million a year ago.
Basic loss per share from continuing operations was USD 0.52 compared to USD 0.6 a year ago. Diluted loss per share from continuing operations was USD 0.52 compared to USD 0.6 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| +58.15% | 2.2B | |
| +10.87% | 115B | |
| +11.74% | 106B | |
| -6.26% | 24.69B | |
| -2.33% | 21.97B | |
| -6.03% | 19.27B | |
| -13.53% | 17.56B | |
| -40.50% | 17.32B | |
| +6.26% | 14.03B | |
| +31.91% | 12.13B |
DECIPHERA PHARMACEUTICALS, INC. 
